US equities
|
SPCX
$167.02
▲+5.07%
NVDA
$237.21
▲+1.39%
MU
$1,064.69
▼-0.95%
TSLA
$377.46
▲+1.85%
MSFT
$525.97
▲+1.63%
INTC
$116.62
▼-2.27%
SNDK
$1,713.32
▼-0.39%
META
$745.47
▲+2.39%
SPCX
$167.02
▲+5.07%
NVDA
$237.21
▲+1.39%
MU
$1,064.69
▼-0.95%
TSLA
$377.46
▲+1.85%
MSFT
$525.97
▲+1.63%
INTC
$116.62
▼-2.27%
SNDK
$1,713.32
▼-0.39%
META
$745.47
▲+2.39%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
ADARx Pharmaceuticals, Inc. - Common stock
(NQ:
ADRX
)
18.49
+0.24 (+1.32%)
Delayed Quote
Updated: 11:18 AM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ADARx Pharmaceuticals, Inc. - Common stock
ADARx Pharmaceuticals Announces the Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares Granted in Its Initial Public Offering
October 01, 2026
From
ADARx Pharmaceuticals Inc.
Via
GlobeNewswire
